Syra Health Corp. Class A Common Stock (SYRA) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 2.27M | 1.73M | 1.69M | 1.95M | 1.86M | 2.01M | 2.25M | 1.97M | 1.75M | 1.77M | 1.58M | 979.25K | 1.19M | 1.97M |
| Revenue Growth % | 22.38% | -13.59% | -25.09% | -1.19% | 6.02% | 13.62% | 42.49% | 101.14% | 47.46% | -10.15% | - | - | - | - |
| Cost of Goods Sold | 1.3M | 1.48M | 1.13M | 1.19M | 1.27M | 1.55M | 1.59M | 1.62M | 1.45M | 1.18M | 1.03M | 851.09K | 1.04M | 1.67M |
| COGS % of Revenue | 57.28% | 85.11% | 67.15% | 61.31% | 68.29% | 77.31% | 70.34% | 82.23% | 82.89% | 67.05% | 64.93% | 86.91% | 87.62% | 85.2% |
| Gross Profit | 971.25K | 258.13K | 554.54K | 752.89K | 589.16K | 455.37K | 668.3K | 350.01K | 299.78K | 582.04K | 554.54K | 128.16K | 147.16K | 290.95K |
| Gross Margin % | 42.72% | 14.89% | 32.85% | 38.69% | 31.71% | 22.69% | 29.66% | 17.77% | 17.11% | 32.95% | 35.07% | 13.09% | 12.38% | 14.8% |
| Gross Profit Growth % | 64.86% | -43.31% | -17.02% | 115.11% | 96.53% | -21.76% | 20.51% | 173.1% | 103.72% | 100.05% | - | - | - | - |
| Operating Expenses | 780.27K | 393.8K | 786.71K | 816.05K | 1.06M | 957.04K | 1.1M | 1.74M | 1.74M | 1.57M | 897.56K | 912.11K | 921.63K | 891.7K |
| OpEx % of Revenue | 34.32% | 22.71% | 46.61% | 41.93% | 57.19% | 47.69% | 48.69% | 88.36% | 99.51% | 88.79% | 56.76% | 93.14% | 77.56% | 45.36% |
| Selling, General & Admin | 213.05K | 393.66K | 780.5K | 780.36K | 1.02M | 954.88K | 288.31K | 1.45M | 1.45M | 1.32M | 885.2K | 899.82K | 909.87K | 875.13K |
| SG&A % of Revenue | 9.37% | 22.7% | 46.24% | 40.1% | 54.82% | 47.58% | 12.79% | 73.37% | 82.95% | 74.5% | 55.98% | 91.89% | 76.57% | 44.52% |
| Research & Development | 6.92K | 139 | 816 | 29.71K | 37.17K | -5.12K | 34.82K | 277.89K | 277.55K | 240.05K | 0 | 0 | 0 | 0 |
| R&D % of Revenue | 0.3% | 0.01% | 0.05% | 1.53% | 2% | -0.26% | 1.55% | 14.11% | 15.84% | 13.59% | - | - | - | - |
| Other Operating Expenses | 560.3K | 0 | 5.4K | 5.98K | 6.8K | 7.28K | 774.08K | 17.37K | 12.54K | 12.41K | 12.36K | 12.29K | 11.76K | 16.57K |
| Operating Income | 190.98K | -135.66K | -232.17K | -63.16K | -473.33K | -501.67K | -428.91K | -1.39M | -1.44M | -986.15K | -343.02K | -783.95K | -774.48K | -600.75K |
| Operating Margin % | 8.4% | -7.82% | -13.75% | -3.25% | -25.48% | -25% | -19.03% | -70.59% | -82.4% | -55.83% | -21.69% | -80.06% | -65.17% | -30.56% |
| Operating Income Growth % | 140.35% | 72.96% | 45.87% | 95.46% | 67.22% | 49.13% | -25.04% | -77.35% | -86.44% | -64.15% | - | - | - | - |
| EBITDA | 192.04K | -133.36K | -228.07K | -57.18K | -466.54K | -494.39K | -403.37K | -1.37M | -1.43M | -973.8K | -330.66K | -771.66K | -762.71K | -590.69K |
| EBITDA Margin % | 8.45% | -7.69% | -13.51% | -2.94% | -25.11% | -24.64% | -17.9% | -69.71% | -81.69% | -55.14% | -20.91% | -78.8% | -64.18% | -30.05% |
| EBITDA Growth % | 141.16% | 73.02% | 43.46% | 95.84% | 67.41% | 49.23% | -21.99% | -77.93% | -87.67% | -64.86% | - | - | - | - |
| D&A (Non-Cash Add-back) | 1.05K | 2.3K | 4.1K | 5.98K | 6.8K | 7.28K | 25.54K | 17.37K | 12.54K | 12.36K | 12.36K | 12.29K | 11.76K | 10.06K |
| EBIT | 190.98K | -135.66K | -225.9K | -59.74K | -469.04K | -498.87K | -415.27K | -1.39M | -1.44M | -986.04K | -340.2K | -783.95K | -774.47K | -600.74K |
| Net Interest Income | 50K | 1.09K | 6.27K | -438 | 1.07K | -2.73K | 11.38K | 97 | -3.1K | -9.12K | -11.36K | -18.85K | -11.42K | -11.88K |
| Interest Income | 52.46K | 5.37K | 8.17K | 3.42K | 4.3K | 2.8K | 13.64K | 3.83K | 981 | 116 | 2.82K | 4 | 2 | 9 |
| Interest Expense | 2.46K | 4.28K | 1.91K | 3.86K | 3.23K | 5.53K | 2.27K | 3.73K | 4.08K | 9.24K | 14.18K | 18.85K | 11.42K | 11.89K |
| Other Income/Expense | 50K | 1.09K | 6.27K | -438 | 1.07K | -2.73K | 11.38K | 97 | -3.1K | -9.12K | -11.36K | -18.85K | -11.42K | -11.88K |
| Pretax Income | 240.98K | -134.57K | -225.9K | -63.6K | -472.26K | -504.4K | -417.54K | -1.39M | -1.45M | -995.27K | -354.38K | -802.8K | -785.89K | -612.63K |
| Pretax Margin % | 10.6% | -7.76% | -13.38% | -3.27% | -25.42% | -25.14% | -18.53% | -70.58% | -82.58% | -56.35% | -22.41% | -81.98% | -66.13% | -31.17% |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Income | 240.98K | -134.57K | -225.9K | -63.6K | -472.26K | -504.4K | -417.54K | -1.39M | -1.45M | -995.27K | -354.38K | -802.8K | -785.89K | -612.63K |
| Net Margin % | 10.6% | -7.76% | -13.38% | -3.27% | -25.42% | -25.14% | -18.53% | -70.58% | -82.58% | -56.35% | -22.41% | -81.98% | -66.13% | -31.17% |
| Net Income Growth % | 151.03% | 73.32% | 45.9% | 95.43% | 67.36% | 49.32% | -17.82% | -73.18% | -84.13% | -62.46% | - | - | - | - |
| Net Income (Continuing) | 240.98K | -134.57K | -225.9K | -63.6K | -472.26K | -504.4K | -417.54K | -1.39M | -1.45M | -995.27K | -354.38K | -802.8K | -785.89K | -612.63K |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | 0.02 | -0.01 | -0.02 | -0.01 | -0.07 | -0.07 | -0.06 | -0.21 | -0.22 | -0.15 | -0.08 | -0.14 | -0.11 | -0.12 |
| EPS Growth % | 128.92% | 83.72% | 67.13% | 97.48% | 70.45% | 53.73% | 29.27% | -50% | -100% | -25% | - | - | - | - |
| EPS (Basic) | 0.02 | -0.01 | -0.02 | -0.01 | -0.07 | -0.07 | -0.06 | -0.21 | -0.22 | -0.15 | -0.08 | -0.14 | -0.18 | -0.12 |
| Diluted Shares Outstanding | 12.78M | 11.94M | 11.94M | 11.94M | 7.26M | 7.26M | 7.26M | 6.6M | 6.5M | 6.42M | 4.36M | 5.86M | 7.28M | 5.15M |
| Basic Shares Outstanding | 11.94M | 11.94M | 11.94M | 11.94M | 7.26M | 7.26M | 7.26M | 6.6M | 6.5M | 6.42M | 4.36M | 5.86M | 4.35M | 5.15M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - |